New registry tracks brain ablation device for Tough-to-Treat epilepsy
NCT ID NCT07546253
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study will collect real-world data from 100 people with drug-resistant epilepsy who receive or are considered for a procedure using the OneRF Ablation System. The system uses radiofrequency energy to target and destroy small areas of brain tissue causing seizures. Researchers will track seizure control, medication changes, and device safety over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this registry could provide real-world evidence on how well the OneRF Ablation System controls seizures in people with drug-resistant epilepsy.
What could go wrong
This is an observational registry, not a controlled trial, so results may be influenced by patient selection or other treatments. It is not designed to prove the device works better than alternatives.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG RESISTANT EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.